Is CI or GSK cheaper?

On trailing earnings, GSK is cheaper: CI trades at a 11.99 P/E and GSK at 11.62.

Which has grown faster, CI or GSK?

Over the past five years, CI grew revenue faster — CI at a 11.28% CAGR versus GSK at 0.63%.

Does CI or GSK pay a bigger dividend?

CI yields 2.21% and GSK yields 3.51% based on trailing dividends and the latest price.

Is CI or GSK more profitable?

GSK runs the higher net margin — CI at 2.26% versus GSK at 17.76%.

Which has been the better investment, CI or GSK?

Over the past 10-year, CI delivered the higher annualized total return — CI at 9.32% versus GSK at 7.50%. Past performance doesn't predict future results.

Cigna Corporation (CI) vs GSK plc (GSK)

GSK leads on 11 of 17 compared metrics.

A side-by-side comparison of Cigna Corporation and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — CI vs GSK

growth of $100 · last 30y

CI +2099.0%GSK +98.1%CI compounded faster

Log scale — wide-divergence pair

CI GSK

CI vs GSK: by the numbers

•GSK is the larger company ($105.20B vs $74.81B market cap).
•GSK trades at the lower earnings multiple (11.62 vs 11.99 P/E).
•GSK converts more revenue to profit (17.76% vs 2.26% net margin).
•CI grew revenue faster over the past five years (11.28% vs 0.63% CAGR).
•GSK pays the higher dividend yield (3.51% vs 2.21%).

Which is better, CI or GSK?

Metric tally: CI 6 · GSK 11

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthCI(faster 5Y revenue CAGR)

IncomeGSK(higher dividend yield)

QualityGSK(higher ROIC)

Metrics side by side

Valuation

Metric	CI	GSK
P/E ratio	11.99	11.62●
Forward P/E	8.46●	13.25
P/S ratio	0.27●	2.42
P/B ratio	1.77●	3.44
PEG ratio	0.15	0.02●
EV / EBITDA	8.13●	8.62
FCF yield	10.26%●	7.87%

Profitability

Metric	CI	GSK
Gross margin	9.30%	72.67%●
Operating margin	3.42%	25.65%●
Net margin	2.26%	17.76%●
ROE	14.90%	25.19%●
ROIC	7.35%	16.61%●

Dividends

Metric	CI	GSK
Dividend yield	2.21%	3.51%●
Payout ratio	27.98%	24.30%

Growth (annualized)

Metric	CI	GSK
Revenue CAGR (5Y)	11.28%●	0.63%
EPS CAGR (5Y)	-0.76%	14.05%●
FCF CAGR (5Y)	-2.03%	-0.35%●
Total return CAGR (5Y)	5.50%	10.18%●

Frequently asked

Which is better, CI or GSK?: It depends on your goal. value: GSK (lower P/E); growth: CI (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 11 to 6.
Is CI or GSK cheaper?: On trailing earnings, GSK is cheaper: CI trades at a 11.99 P/E and GSK at 11.62.
Which has grown faster, CI or GSK?: Over the past five years, CI grew revenue faster — CI at a 11.28% CAGR versus GSK at 0.63%.
Does CI or GSK pay a bigger dividend?: CI yields 2.21% and GSK yields 3.51% based on trailing dividends and the latest price.
Is CI or GSK more profitable?: GSK runs the higher net margin — CI at 2.26% versus GSK at 17.76%.
Which has been the better investment, CI or GSK?: Over the past 10-year, CI delivered the higher annualized total return — CI at 9.32% versus GSK at 7.50%. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio GSK P/E ratio Cigna dividend yield GSK dividend yield Cigna ROE GSK ROE Cigna operating margin GSK operating margin Cigna revenue growth GSK revenue growth Cigna free cash flow GSK free cash flow

Cigna & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.